Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ

$2.21

$--

(0.00%)

Pre-Market

Eledon Pharmaceuticals, Inc. (ELDN) Live Price Chart

Last updated: ⁦2026-10-27 10:29:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Eledon Pharmaceuticals, Inc. (ELDN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.21, with a market capitalization of $186.90M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.35 to $4.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$186.90M
Open	$2.21
Day's High	$22.91
Day's Low	$1.07
Previous Close	$2.21
Volume	1.00
Average Volume	878.48K
P/E Ratio	--
52-Week High	$4.60
52-Week Low	$1.35
Dividend Yield	--
Earnings Date	--

Eledon Pharmaceuticals, Inc. (ELDN) Pre-Market Stock Price

Eledon Pharmaceuticals, Inc. (ELDN) is trading at $2.21 in pre-market trading as of 2026-10-27 09:15:00, unchanged from the previous close of $2.21

Pre-market trading shows how investors are pricing ELDN before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Eledon Pharmaceuticals, Inc. (ELDN) 7-Day Stock Price Change

Over the past seven days, Eledon Pharmaceuticals, Inc. (ELDN) moved from $2.13 to $2.21, representing a gain of 3.76% ($0.08).

The stock traded between $2.11 and $2.42 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.

The average daily volume was 688.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ELDN 52-Week Price Position

Position in Range: 26.5%

52W Low$1.35

52W High$4.60

ELDN is currently trading at $2.21, placing it 26.5% of the way from its 52-week low of $1.35 to its 52-week high of $4.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Eledon Pharmaceuticals, Inc. (ELDN)?

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Eledon Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	33
Exchange	NASDAQ
Company Website	https://www.eledon.com

How to Buy Eledon Pharmaceuticals, Inc. (ELDN) Stock on MEXC

Eligible investors can buy real shares of Eledon Pharmaceuticals, Inc. (ELDN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ELDN and Place Your Order

Open the RealStocks trading page and search for ELDN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Eledon Pharmaceuticals, Inc. (ELDN) stock price today?

Eledon Pharmaceuticals, Inc. (ELDN) is currently trading at $ 2.21, unchanged from the previous close of $ 2.21. Intraday prices update in real time during regular trading hours.

2.Is ELDN stock going up or down today?

As of 2026-10-27 09:15:00, ELDN is trading at $ 2.21, unchanged from its previous close of $ 2.21. The stock has traded between $ 1.07 and $ 22.91 during today’s regular session. Past price movements do not guarantee future results.

3.What is ELDN pre-market price?

As of 2026-10-27 09:15:00, ELDN is trading at $ 2.21 in pre-market trading, unchanged from the previous close of $ 2.21. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ELDN after-hours price?

As of 2026-10-27 09:15:00, ELDN is trading at $ 2.21 in after-hours trading, unchanged from the regular-session close of $ 2.21. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ELDN stock trading now?

ELDN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ELDN sit relative to its 52-week high and low?

Over the past 52 weeks, ELDN has traded between a low of $ 1.35 and a high of $ 4.60. At $ 2.21, the stock is positioned 26.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Eledon Pharmaceuticals, Inc. in?

Eledon Pharmaceuticals, Inc. (ELDN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Eledon Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Eledon Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 186.90M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ELDN valued in terms of P/E ratio and EPS?

ELDN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Eledon Pharmaceuticals, Inc. pay a dividend?

Eledon Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.